Key result
Recent use of statins was inversely associated with hospitalization due to severe hyponatremia compared to matched controls.
Why the study?
Limited evidence suggests an inverse association between statins and hyponatremia, while data on other lipid-lowering agents is absent.
Does the use of lipid-lowering agents increase the risk of hospitalization due to hyponatremia in the general adult population?
Case-Control (n=56,014)
Does the use of lipid-lowering agents increase the risk of hospitalization due to hyponatremia in the general adult population?
Statins and ezetimibe are inversely associated with hospitalization for severe hyponatremia, suggesting they are safe to initiate and continue in patients at risk for or experiencing hyponatremia.
Answers are grounded in this paper and cite their sources.
Does not support avoiding statins for hyponatremia concerns; leaves open potential protective effects needing prospective confirmation.
PURPOSE: Drug-induced hyponatremia is common, with medications from many drug-classes implicated. Lipid-lowering agents are among the most prescribed drugs. Limited evidence suggests an inverse association between statins and hyponatremia, while data on other lipid-lowering agents is absent. The objective of this investigation was to study the association between lipid-lowering drugs and hospitalization due to hyponatremia. METHODS: This was a register-based case-control study of the general Swedish population. Those hospitalized with a main diagnosis of hyponatremia (n = 11,213) were compared with matched controls (n = 44,801). Multivariable logistic regression adjusting for co-medication, diseases, previous hospitalizations, and socioeconomic factors was used to explore the association between severe hyponatremia and the use of lipid-lowering drugs. RESULTS: Unadjusted ORs (95% CI) for hospitalization due to hyponatremia were 1.28 (1.22-1.35) for statins, 1.09 (0.79-1.47) for ezetimibe, 1.38 (0.88-2.12) for fibrates, and 2.12 (1.31-3.35) for resins. After adjustment for confounding factors the adjusted odds ratios (95% CI) compared with controls were 0.69 (0.64-0.74) for statins, 0.60 (0.41-0.86) for ezetimibe, 0.87 (0.51-1.42) for fibrates, and 1.21 (0.69-2.06) for resins. CONCLUSIONS: Use of statins and ezetimibe was inversely correlated with severe hyponatremia. Consequently, these drugs are unlikely culprits in patients with hyponatremia, and they appear safe to initiate in hyponatremic patients. A potential protective effect warrants further studies on how statins and other lipid-lowering drugs are linked to dysnatremias.
No takes yet. Share an insight, caveat, or question.
Skov et al. (2020) conducted a case-control in Severe hyponatremia (n=56,014). Statins vs. Matched controls (non-users) was evaluated on Hospitalization due to severe hyponatremia (OR 0.69, 95% CI 0.64-0.74). Recent use of statins was inversely associated with hospitalization due to severe hyponatremia compared to matched controls.
Synapse has enriched 10 related papers. Consider them for comparative context: